American Association for Cancer Research presents scientific awards

The American Association for Cancer Research will present several scientific awards during its annual meeting, scheduled for April 14-18 in Chicago.

Recipients include:

Leslie Bernstein, PhD, professor in the division of biomarkers of early detection and prevention at Beckman Research Institute at City of Hope, will receive the AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention. The award recognizes outstanding research accomplishments in cancer epidemiology, biomarkers and prevention. Bernstein will be recognized for her contributions showing the impact that lifestyle and reproductive factors have on breast cancer risk and survival.

Johann S. de Bono, MD, PhD, will receive the AACR-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research. De Bono is Regius professor of cancer research, professor of experimental cancer medicine, and honorary consultant in medical oncology at The Institute of Cancer Research and Royal Marsden NHS Foundation Trust in England. His work has led to several drug approvals, and his hypothesis-driven approach changed the way the clinical community views the biology of late-stage prostate cancer.

Antoni Ribas, MD, PhD, will receive the AACR-CRI Lloyd J. Old Award in Cancer Immunology. The award recognizes an active scientist whose outstanding and innovative research in cancer immunology has had a far-reaching impact on the cancer field. Ribas is professor of medicine, surgery, and molecular and medical pharmacology, director of the tumor immunology program at Jonsson Comprehensive Cancer Center, and director of Parker Institute for Cancer Immunotherapy Center at UCLA.

John A. Katzenellenbogen, PhD, professor of chemistry at University of Illinois at Urbana-Champaign, will receive the AACR Award for Outstanding Achievement in Chemistry in Cancer Research. The award recognizes outstanding, novel and significant chemistry research that has led to important contributions to the fields of basic cancer research, translational cancer research, cancer diagnosis, cancer prevention and treatment.

Scott W. Lowe, PhD, will receive the AACR G.H.A. Clowes Memorial Award, which recognizes outstanding recent accomplishments in basic cancer research. Lowe — chair of the cancer biology and genetics program at Memorial Sloan Kettering Cancer Center — will be honored for research on the mechanisms of tumor suppression, as well as his contributions to the understanding of p53 biology and for development RNA1 screens for target validation and drug discovery involving the p53 signaling axis.

Isaiah J. Fidler, DVM, PhD, FAACR, will receive the Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research. Fidler is professor in the departments of cancer biology and neurosurgery at The University of Texas MD Anderson Cancer Center. He served as AACR president from 1984 to 1985.

Joseph R. Bertino, MD, FAACR, will receive the AACR Award for Lifetime Achievement in Cancer Research. Bertino — HemOnc Today s founding chief medical editor and consulting editor for oncology — is medical oncologist and senior adviser to the director of Rutgers Cancer Institute of New Jersey, as well as professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School.

Patrick Tan, MD, PhD, will receive the AACR Team Science Award, which recognizes an outstanding interdisciplinary research team for its innovative and meritorious science that has advanced or will advance knowledge of cancer, or a team that has applied existing knowledge to advance the detection, diagnosis, prevention or treatment of cancer. Tan is professor at Duke-NUS Medical School, as well as senior principal investigator at Cancer Science Institute of Singapore.

Jennifer A. Doudna, PhD, FAACR, will receive the AACR-Irving Weinstein Foundation Distinguished Lecture, which recognizes an individual whose outstanding personal innovation in science has the potential to inspire creative thinking and new directions in cancer research. Doudna is chair in biomedical and health sciences, as well as professor in the departments of chemistry and molecular/cell biology, at UC Berkeley.

Tony R. Hunter, PhD, FAACR, will receive the Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research. Hunter is chair of and professor at The Salk Institute.

Lisa M. Coussens, PhD, will receive the AACR-Princess Takamatsu Memorial Lectureship, which recognizes a scientist whose novel and significant work has had or may have a far-reaching impact on the detection, diagnosis, treatment or prevention of cancer, and who embodies the dedication of the princess to multinational collaborations. Coussens is chairwoman of the department of cell, developmental and cancer biology, as well as associate director for basic research at Knight Cancer Institute.

Pasi A. Jänne, MD, PhD, will receive the AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research. Jänne is director of Lowe Center for Thoracic Oncology and director of Belfer Center for Applied Cancer Science at Dana-Farber Cancer Institute, and professor of medicine at Harvard Medical School.

John D. Carpten, PhD, will receive the AACR-Minorities in Cancer Research Jane Cooke Wright memorial Lectureship, which recognizes a scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of minority investigation in cancer research. Carpten is chair of the department of translational genomics at University of Southern California Keck School of Medicine.

Dafna Bar-Sagi, PhD, will receive the AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship, presented to a scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of women in science. Bar-Sagi is senior vice president, vice dean for science and chief scientific officer at NYU Langone Medical Center.

The American Association for Cancer Research will present several scientific awards during its annual meeting, scheduled for April 14-18 in Chicago.

Recipients include:

Leslie Bernstein, PhD, professor in the division of biomarkers of early detection and prevention at Beckman Research Institute at City of Hope, will receive the AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention. The award recognizes outstanding research accomplishments in cancer epidemiology, biomarkers and prevention. Bernstein will be recognized for her contributions showing the impact that lifestyle and reproductive factors have on breast cancer risk and survival.

Johann S. de Bono, MD, PhD, will receive the AACR-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research. De Bono is Regius professor of cancer research, professor of experimental cancer medicine, and honorary consultant in medical oncology at The Institute of Cancer Research and Royal Marsden NHS Foundation Trust in England. His work has led to several drug approvals, and his hypothesis-driven approach changed the way the clinical community views the biology of late-stage prostate cancer.

Antoni Ribas, MD, PhD, will receive the AACR-CRI Lloyd J. Old Award in Cancer Immunology. The award recognizes an active scientist whose outstanding and innovative research in cancer immunology has had a far-reaching impact on the cancer field. Ribas is professor of medicine, surgery, and molecular and medical pharmacology, director of the tumor immunology program at Jonsson Comprehensive Cancer Center, and director of Parker Institute for Cancer Immunotherapy Center at UCLA.

John A. Katzenellenbogen, PhD, professor of chemistry at University of Illinois at Urbana-Champaign, will receive the AACR Award for Outstanding Achievement in Chemistry in Cancer Research. The award recognizes outstanding, novel and significant chemistry research that has led to important contributions to the fields of basic cancer research, translational cancer research, cancer diagnosis, cancer prevention and treatment.

Scott W. Lowe, PhD, will receive the AACR G.H.A. Clowes Memorial Award, which recognizes outstanding recent accomplishments in basic cancer research. Lowe — chair of the cancer biology and genetics program at Memorial Sloan Kettering Cancer Center — will be honored for research on the mechanisms of tumor suppression, as well as his contributions to the understanding of p53 biology and for development RNA1 screens for target validation and drug discovery involving the p53 signaling axis.

Isaiah J. Fidler, DVM, PhD, FAACR, will receive the Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research. Fidler is professor in the departments of cancer biology and neurosurgery at The University of Texas MD Anderson Cancer Center. He served as AACR president from 1984 to 1985.

Joseph R. Bertino, MD, FAACR, will receive the AACR Award for Lifetime Achievement in Cancer Research. Bertino — HemOnc Today s founding chief medical editor and consulting editor for oncology — is medical oncologist and senior adviser to the director of Rutgers Cancer Institute of New Jersey, as well as professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School.

Patrick Tan, MD, PhD, will receive the AACR Team Science Award, which recognizes an outstanding interdisciplinary research team for its innovative and meritorious science that has advanced or will advance knowledge of cancer, or a team that has applied existing knowledge to advance the detection, diagnosis, prevention or treatment of cancer. Tan is professor at Duke-NUS Medical School, as well as senior principal investigator at Cancer Science Institute of Singapore.

Jennifer A. Doudna, PhD, FAACR, will receive the AACR-Irving Weinstein Foundation Distinguished Lecture, which recognizes an individual whose outstanding personal innovation in science has the potential to inspire creative thinking and new directions in cancer research. Doudna is chair in biomedical and health sciences, as well as professor in the departments of chemistry and molecular/cell biology, at UC Berkeley.

Tony R. Hunter, PhD, FAACR, will receive the Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research. Hunter is chair of and professor at The Salk Institute.

Lisa M. Coussens, PhD, will receive the AACR-Princess Takamatsu Memorial Lectureship, which recognizes a scientist whose novel and significant work has had or may have a far-reaching impact on the detection, diagnosis, treatment or prevention of cancer, and who embodies the dedication of the princess to multinational collaborations. Coussens is chairwoman of the department of cell, developmental and cancer biology, as well as associate director for basic research at Knight Cancer Institute.

Pasi A. Jänne, MD, PhD, will receive the AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research. Jänne is director of Lowe Center for Thoracic Oncology and director of Belfer Center for Applied Cancer Science at Dana-Farber Cancer Institute, and professor of medicine at Harvard Medical School.

John D. Carpten, PhD, will receive the AACR-Minorities in Cancer Research Jane Cooke Wright memorial Lectureship, which recognizes a scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of minority investigation in cancer research. Carpten is chair of the department of translational genomics at University of Southern California Keck School of Medicine.

Dafna Bar-Sagi, PhD, will receive the AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship, presented to a scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of women in science. Bar-Sagi is senior vice president, vice dean for science and chief scientific officer at NYU Langone Medical Center.

    See more from American Association for Cancer Research Annual Meeting